ACTAVIS PHARMA
DEAD

Serial Number

85830300

Owner

ACTAVIS, INC.

Attorney

GABRIELLE S. ROTH

Filing Date

Jan 23, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ACTAVIS PHARMA Trademark

Serial Number: 85830300

ACTAVIS PHARMA is a trademark filed by ACTAVIS, INC. on January 23, 2013. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). The application is currently no longer active.

Owner Contact Info

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

ACTAVIS HOLDCO US, INC. (65 trademarks)

PARSIPPANY, NJ 07054

Entity Type: 03

Actavis Group PTC ehf (50 trademarks)

Dalshraun 1

Entity Type: 78

Trademark Details

Filing Date

January 23, 2013

Registration Date

Not Registered

Published for Opposition

February 4, 2014

Goods & Services

Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development

Pharmaceuticals, namely, preparations and substances for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators, sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators

Soaps, perfumery, essential oils, cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes; cosmetic preparations for the care of mouth and teeth; skin and hair care preparations not for medical use

Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Apr 9, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 9, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2017 EXRA
SOU EXTENSION 5 GRANTED
Sep 18, 2017 EX5G
SOU EXTENSION 5 FILED
Sep 5, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2017 EXRA
SOU EXTENSION 4 GRANTED
Mar 3, 2017 EX4G
SOU EXTENSION 4 FILED
Mar 3, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 3, 2017 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 22, 2017 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 14, 2016 EXRA
SOU EXTENSION 3 GRANTED
Sep 13, 2016 EX3G
SOU EXTENSION 3 FILED
Sep 6, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 6, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2016 EXRA
SOU EXTENSION 2 GRANTED
Mar 11, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 10, 2016 AITU
SOU EXTENSION 2 FILED
Feb 9, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 9, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2015 EXRA
SOU EXTENSION 1 GRANTED
Aug 24, 2015 EX1G
SOU EXTENSION 1 FILED
Aug 24, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 24, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2015 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jan 20, 2015 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 20, 2015 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 6, 2015 OP.D
OPPOSITION INSTITUTED NO. 999999
Jul 31, 2014 OP.I
UNDELIVERABLE MAIL - NO ACTION TAKEN
Jul 18, 2014 UNDN
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 27, 2014 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2014 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 15, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 28, 2013 PREV
ASSIGNED TO LIE
Dec 27, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 3, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 3, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 3, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 3, 2013 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 24, 2013 GNFN
FINAL REFUSAL E-MAILED
Nov 24, 2013 GNFR
FINAL REFUSAL WRITTEN
Nov 24, 2013 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2013 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2013 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2013 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2013 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2013 CNRT
ASSIGNED TO EXAMINER
May 3, 2013 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 20, 2013 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2013 NWOS
NEW APPLICATION ENTERED
Jan 26, 2013 NWAP